Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alistair M. Cook, Alison McDonnell, Michael J Millward, Jenette Creaney, Arman Hasani, Michelle McMullen, Tarek Meniawy, Bruce W.S. Robinson, Richard a Lake & Anna K. Nowak. (2021) A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers. Expert Review of Anticancer Therapy 21:5, pages 465-474.
Read now
Read now
Articles from other publishers (22)
Mingliang Fan, Jiayu Zheng, Yue Huang, Hongxu Lu & Mingxia Lu. (2023) Transdermal therapeutic systems in breast cancer therapy. Journal of Drug Delivery Science and Technology 90, pages 105139.
Crossref
Crossref
Elena Muraro, Lorenzo Vinante, Elisabetta Fratta, Alessandra Bearz, Daniela Höfler, Agostino Steffan & Lorena Baboci. (2023) Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors. Cancers 15:9, pages 2471.
Crossref
Crossref
Arthur Xuan Wang, Xiao Jing Ong, Criselle D’Souza, Paul J. Neeson & Joe Jiang Zhu. (2023) Combining chemotherapy with CAR-T cell therapy in treating solid tumors. Frontiers in Immunology 14.
Crossref
Crossref
Xian Chen, Rui Zhou, Yong Li, Xin Qu, Yan-chun Qu, Wen-zhu Li, Yong-song Ye, Li-rong Liu, Yan-juan Zhu & Hai-bo Zhang. (2022) Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers. Frontiers in Immunology 13.
Crossref
Crossref
Motoki Hojo, Ai Maeno, Yoshimitsu Sakamoto, Aya Ohnuki, Yukie Tada, Yukio Yamamoto, Kiyomi Ikushima, Ryota Inaba, Jin Suzuki, Yuhji Taquahashi, Satoshi Yokota, Norihiro Kobayashi, Makoto Ohnishi, Yuko Goto, Takamasa Numano, Hiroyuki Tsuda, David B. Alexander, Jun Kanno, Akihiko Hirose, Akiko Inomata & Dai Nakae. (2022) Two-year intermittent exposure of a multiwalled carbon nanotube by intratracheal instillation induces lung tumors and pleural mesotheliomas in F344 rats. Particle and Fibre Toxicology 19:1.
Crossref
Crossref
Feng Shan, Ashwin Somasundaram, Tullia C. Bruno, Creg J. Workman & Dario A.A. Vignali. (2022) Therapeutic targeting of regulatory T cells in cancer. Trends in Cancer 8:11, pages 944-961.
Crossref
Crossref
Rokon Uz Zaman, Rikhav P. Gala, Amit Bansal, Priyal Bagwe & Martin J. D'Souza. (2022) Preclinical evaluation of a microparticle-based transdermal vaccine patch against metastatic breast cancer. International Journal of Pharmaceutics 627, pages 122249.
Crossref
Crossref
N. Richardson, G. E. Wootton, A. G. Bozward & Y. H. Oo. (2022) Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease. Seminars in Immunopathology 44:4, pages 461-474.
Crossref
Crossref
Ming Yi, Xiaoli Zheng, Mengke Niu, Shuangli Zhu, Hong Ge & Kongming Wu. (2022) Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Molecular Cancer 21:1.
Crossref
Crossref
Chunwan Lu, Dafeng Yang, John D Klement, Yolonda L Colson, Nicholas H Oberlies, Cedric J Pearce, Aaron H Colby, Mark W Grinstaff, Han-Fei Ding, Huidong Shi & Kebin Liu. (2022) G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes. Journal for ImmunoTherapy of Cancer 10:1, pages e003543.
Crossref
Crossref
Paul V. Munson, Lisa H. Butterfield & Juraj Adamik. 2022. Cancer Vaccines as Immunotherapy of Cancer. Cancer Vaccines as Immunotherapy of Cancer
109
135
.
Francesca Cersosimo, Marcella Barbarino, Silvia Lonardi, William Vermi, Antonio Giordano, Cristiana Bellan & Emanuele Giurisato. (2021) Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms. Cancers 13:22, pages 5664.
Crossref
Crossref
Jitka Fucikova, An Coosemans, Sandra Orsulic, David Cibula, Ignace Vergote, Lorenzo Galluzzi & Radek Spisek. (2021) Immunological configuration of ovarian carcinoma: features and impact on disease outcome. Journal for ImmunoTherapy of Cancer 9:10, pages e002873.
Crossref
Crossref
James Harber, Tamihiro Kamata, Catrin Pritchard & Dean Fennell. (2021) Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy. Journal for ImmunoTherapy of Cancer 9:9, pages e003032.
Crossref
Crossref
Daphne W. Dumoulin, Robin Cornelissen, Koen Bezemer, Sara J. Baart & Joachim G. J. V. Aerts. (2021) Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials. Vaccines 9:5, pages 525.
Crossref
Crossref
Jun-Yan Li, Yu-Pei Chen, Ying-Qin Li, Na Liu & Jun Ma. (2021) Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades. Molecular Cancer 20:1.
Crossref
Crossref
Lei Cheng, Na Li, Xiao-ling Xu & Wei-Min Mao. (2020) Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma. Current Drug Targets 21:15, pages 1606-1612.
Crossref
Crossref
Micaela Orsi, Chafik Al Hatem, Riccardo Leinardi & François Huaux. (2020) Carbon Nanotubes under Scrutiny: Their Toxicity and Utility in Mesothelioma Research. Applied Sciences 10:13, pages 4513.
Crossref
Crossref
Robert A. Belderbos, Heleen Vroman & Joachim G. J. V. Aerts. (2020) Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma. Frontiers in Oncology 10.
Crossref
Crossref
Natalia Trempolec, Charline Degavre, Bastien Doix, Davide Brusa, Cyril Corbet & Olivier Feron. (2020) Acidosis-Induced TGF-β2 Production Promotes Lipid Droplet Formation in Dendritic Cells and Alters Their Potential to Support Anti-Mesothelioma T Cell Response. Cancers 12:5, pages 1284.
Crossref
Crossref
Lenka Fedorova, Peter Mudry, Katerina Pilatova, Iveta Selingerova, Jana Merhautova, Zdenek Rehak, Dalibor Valik, Eva Hlavackova, Dasa Cerna, Lucie Faberova, Pavel Mazanek, Zdenek Pavelka, Regina Demlova, Jaroslav Sterba & Lenka Zdrazilova-Dubska. (2019) Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma. Frontiers in Oncology 9.
Crossref
Crossref
Robert A. Belderbos, Joachim G.J.V. Aerts & Heleen Vroman. (2019) Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment. Molecular Therapy - Oncolytics 13, pages 67-81.
Crossref
Crossref